Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/eje.0.1490403
European Journal of Endocrinology, Vol 149, Issue 5, 403-406
Copyright © 2003 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Briatore, L
Right arrow Articles by Cordera, R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Briatore, L
Right arrow Articles by Cordera, R

Articles

Acute plasma glucose increase, but not early insulin response, regulates plasma ghrelin

L Briatore, G Andraghetti, and R Cordera

Department of Endocrinology and Metabolism, University of Genoa, Viale Benedetto XV 6, 16132 Genoa, Italy.

OBJECTIVE: The independent role of glucose and insulin in ghrelin regulation is still controversial; this is also because in healthy subjects it is difficult to isolate the increase of glucose from that of insulin. The aim of this study was to discriminate the effect of glucose increase alone and early insulin response on plasma ghrelin, comparing ghrelin variation after i.v. glucose between healthy subjects and type 2 diabetic (T2DM) subjects, in whom the early insulin response to i.v. glucose is abolished. METHODS: Plasma glucose, insulin and ghrelin levels were measured 0, 3, 5, 10, 30, 45 and 60 min after a 5 g glucose i.v. bolus in seven healthy control subjects and eight T2DM subjects. RESULTS: There were no significant differences in body mass index, basal insulin and basal ghrelin between T2DM and healthy subjects. Basal glucose levels were higher in T2DM subjects than in controls. After i.v. glucose administration, plasma glucose increased significantly in both groups and the glucose peak was higher in T2DM subjects than in controls (9.67+/-1.25 (s.d.) vs 6.88+/-1.00 mmol/l, P<0.01). Insulin increased rapidly in controls, while in T2DM subjects, plasma insulin did not rise in the first 10 min. After the glucose bolus, plasma ghrelin showed a significant reduction both in controls and in T2DM subjects after 5 min. CONCLUSION: These findings indicate that a low-dose i.v. glucose bolus reduces ghrelin both in controls and in T2DM subjects and therefore that early insulin response does not affect plasma ghrelin.


This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
U. Mager, M. Kolehmainen, V. D F de Mello, U. Schwab, D. E Laaksonen, R. Rauramaa, H. Gylling, M. Atalay, L. Pulkkinen, and M. Uusitupa
Expression of ghrelin gene in peripheral blood mononuclear cells and plasma ghrelin concentrations in patients with metabolic syndrome.
Eur. J. Endocrinol., April 1, 2008; 158(4): 499 - 510.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Gauna, P. Uitterlinden, P. Kramer, R. M. Kiewiet, J. A. M. J. L. Janssen, P. J. D. Delhanty, M. O. van Aken, E. Ghigo, L. J. Hofland, A. P. N. Themmen, et al.
Intravenous Glucose Administration in Fasting Rats Has Differential Effects on Acylated and Unacylated Ghrelin in the Portal and Systemic Circulation: A Comparison between Portal and Peripheral Concentrations in Anesthetized Rats
Endocrinology, November 1, 2007; 148(11): 5278 - 5287.
[Abstract] [Full Text] [PDF]


Home page
J ANIM SCIHome page
M. E. Gordon and K. H. McKeever
Oral and intravenous carbohydrate challenges decrease active ghrelin concentrations and alter hormones related to control of energy metabolism in horses
J Anim Sci, July 1, 2006; 84(7): 1682 - 1690.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
M A Arafat, B Otto, H Rochlitz, M Tschop, V Bahr, M Mohlig, S Diederich, J Spranger, and A F H Pfeiffer
Glucagon inhibits ghrelin secretion in humans
Eur. J. Endocrinol., September 1, 2005; 153(3): 397 - 402.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Daousi, I. A. MacFarlane, P. J. English, J. P. H. Wilding, M. Patterson, T. M. Dovey, J. C. G. Halford, M. A. Ghatei, and J. H. Pinkney
Is There a Role for Ghrelin and Peptide-YY in the Pathogenesis of Obesity in Adults with Acquired Structural Hypothalamic Damage?
J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5025 - 5030.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
U. Jaakkola, T. Kuusela, T. Jartti, U. Pesonen, M. Koulu, T. Vahlberg, and J. Kallio
The Leu7Pro Polymorphism of PreproNPY Is Associated with Decreased Insulin Secretion, Delayed Ghrelin Suppression, and Increased Cardiovascular Responsiveness to Norepinephrine during Oral Glucose Tolerance Test
J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3646 - 3652.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Arosio, C. L. Ronchi, P. Beck-Peccoz, C. Gebbia, C. Giavoli, V. Cappiello, D. Conte, and M. Peracchi
Effects of Modified Sham Feeding on Ghrelin Levels in Healthy Human Subjects
J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 5101 - 5104.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 European Society of Endocrinology.